Page 28 - Read Online

Page 12 of 12 Housman et al. J Cancer Metastasis Treat 2021;7:69 https://dx.doi.org/10.20517/2394-4722.2021.159

prognosis. Interact Cardiovasc Thorac Surg 2008;7:102-6. DOI PubMed
36. Luckraz H, Rahman M, Patel N, Szafranek A, Gibbs AR, Butchart EG. Three decades of experience in the surgical multi-modality
management of pleural mesothelioma. Eur J Cardiothorac Surg 2010;37:552-6. DOI PubMed
37. Cao C, Tian D, Park J, Allan J, Pataky KA, Yan TD. A systematic review and meta-analysis of surgical treatments for malignant
pleural mesothelioma. Lung Cancer 2014;83:240-5. DOI PubMed
38. Taioli E, Wolf AS, Flores RM. Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in
mesothelioma. Ann Thorac Surg 2015;99:472-80. DOI PubMed
39. Aziz T. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg
2002;22:298-305. DOI PubMed
40. Magouliotis DE, Tasiopoulou VS, Athanassiadi K. Updated meta-analysis of survival after extrapleural pneumonectomy versus
pleurectomy/decortication in mesothelioma. Gen Thorac Cardiovasc Surg 2019;67:312-20. DOI PubMed
41. Bölükbas S, Eberlein M, Schirren J. Prospective study on functional results after lung-sparing radical pleurectomy in the management
of malignant pleural mesothelioma. J Thorac Oncol 2012;7:900-5. DOI PubMed
42. Batirel HF, Metintas M, Caglar HB, et al. Macroscopic complete resection is not associated with improved survival in patients with
malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2018;155:2724-33. DOI PubMed
43. Lim E, Darlison L, Edwards J, et al; MARS 2 Trialists. Mesothelioma and radical surgery 2 (MARS 2): protocol for a multicentre
randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with
malignant pleural mesothelioma. BMJ Open 2020;10:e038892. DOI PubMed PMC
44. Baldini EH, Recht A, Strauss GM, et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac
Surg 1997;63:334-8. DOI PubMed
45. Manegold C, Symanowski J, Gatzemeier U, et al. Second-line (post-study) chemotherapy received by patients treated in the phase III
trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma. Ann Oncol 2005;16:923-7. DOI PubMed
46. Jassem J, Ramlau R, Santoro A, et al. Phase III trial of pemetrexed plus best supportive care compared with best supportive care in
previously treated patients with advanced malignant pleural mesothelioma. J Clin Oncol 2008;26:1698-704. DOI PubMed
47. Wolf A, Gill RR, Baldini EH, et al. Patterns of recurrence following pleurectomy/decortication for malignant pleural mesothelioma. In:
11th International Conference of the International Mesothelioma Interest Group. Boston, MA, USA, December 28, 2012.
48. Weder W, Stahel RA, Baas P, et al. The MARS feasibility trial: conclusions not supported by data. Lancet Oncol 2011;12:1093-4.
DOI
49. Scherpereel A, Astoul P, Baas P, et al; European Respiratory Society, European Society of Thoracic Surgeons. [Guidelines of the
European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural
mesothelioma]. Zhongguo Fei Ai Za Zhi 2010;13:C23-45. DOI PubMed PMC
50. Gupta V, Mychalczak B, Krug L, et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural
mesothelioma. Int J Radiat Oncol Biol Phys 2005;63:1045-52. DOI PubMed
51. Allen AM, Czerminska M, Jänne PA, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
Int J Radiat Oncol Biol Phys 2006;65:640-5. DOI PubMed
52. Rimner A, Zauderer MG, Gomez DR, et al. Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT)
as part of lung-sparing multimodality therapy in patients with malignant pleural mesothelioma. J Clin Oncol 2016;34:2761-8. DOI
PubMed PMC
53. Stahel RA, Riesterer O, Xyrafas A, et al. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural
mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial. Lancet
Oncol 2015;16:1651-8. DOI PubMed
54. Minatel E, Trovo M, Polesel J, et al. Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant
pleural mesothelioma. Final results with long-term follow-up. Lung Cancer 2014;83:78-82. DOI PubMed